Evotec AG (investor - Corporate Investor)
See something wrong or missing? Let us know
Offices:Hamburg
Evotec SE is a publicly listed drug discovery and development company that operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists.
Average round investment:57.66M USD
Average number per year:1.2
Mostly invests in:
United Kingdom (4)
Biotech (7)

See the entire list
Showing 3 of 7 tracked investments in:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Evotec AG mostly invests with:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Investors with similar profile to Evotec AG
Name | Criteria | |
---|---|---|
![]() |
SR One
83%
|
|
![]() |
3i
83%
|
|
![]() |
Medicxi
83%
|
|
![]() |
Thiel Capital
83%
|
|
![]() |
What If Ventures
83%
|
|
![]() |
GT Healthcare Capital
83%
|
|
![]() |
Charles River Laboratories
83%
|
|
![]() |
Cowen Healthcare Investments
83%
|
|
![]() |
Atlas Venture
83%
|
|
![]() |
LG Electronics
83%
|
|